05 May 2026
Paul Rosie Joins Goodwin Life Sciences Group in Boston
"Paul Rosie joins Goodwin’s Life Sciences group in Boston as a partner, focusing on life sciences and technology corporate matters including venture capital, M&A and capital markets."
Rosie advises high-growth companies and investors across the full corporate lifecycle, including venture capital financings, mergers and acquisitions, and capital markets transactions. He represents startups through later-stage companies, as well as venture capital funds, with a focus on the life sciences and technology industries. His experience spans pre-incorporation planning, equity financings, strategic transactions, exits, and a range of M&A deals and public offerings. He joins Goodwin as a partner in the Boston office.